6 NEWS SYNERGY NEWS FEBRUARY 2014 www.sor.org


Vasa praevia and placenta praevia screening will not be introduced


Decision is ‘unsurprising’, says SoR


The UK National Screening Committee (UK NSC) has published its recommendations on screening for vasa praevia and placenta praevia.


It has recommended that national screening programmes


for these two conditions should not be introduced at the present time. Audrey Paterson, director of professional policy for the SoR, commented: “The decision of the UK NSC in relation to vasa praevia is not surprising although there will be parents who will be deeply disappointed by this. “Sonographers, our members, play lead roles in the diagnosis of this condition and, equally, some will feel strongly that a different decision should have been made. “The matter will be considered again in approximately


three years’ time and, if a different conclusion and decision is to be made, there will be a need for additional high quality, robust evidence to be available by that time, as well as agreed clinical management strategies. “The SoR will seek to work with the medical royal colleges, professional bodies and other stakeholders to encourage relevant research and to secure the development of appropriate clinical guidelines for the higher risk group of women identified by the NSC report.” Read the recommendations at bit.ly/1jFicru and at bit.ly/19QKwqf


Nuclear medicine advisory group pushes forward with new agenda


The Nuclear Medicine Advisory Group (NMAG) will be pushing forward with new agendas and workstreams in 2014. Members of the group


recently met in order to align the work of the group with the rapid development of clinical Nuclear Medicine and


PET in the UK. At the first meeting, members welcomed David Wyn Jones as NMAG’s new chair, and Amy Wareing as vice chair. David, who currently leads the nuclear medicine service in North Wales for the Betsi Cadwaladr University Health Board, and Amy, a lecturer in radiography at Robert Gordon University, aim to support the group during this exciting, but demanding period of development.


David commented: “After the first meeting, members left feeling very positive about the future of nuclear medicine, and the support that the SoR can offer, in terms of providing advice on training, role development and skill mix.” With ongoing


dwindling resources, and opportunities for role development ever expanding, the contribution of this group will be pivotal.


Continued David: “I am really pleased to be able to help steer the work of this group. Much is already being done to shape a new scope of practice document. I


feel this group has a new impetus for moving on with this essential work, and I’m looking forward to working closely with fellow members. They are all accomplished individuals, passionate about nuclear medicine, and drawn from a diverse but relevant background.” NMAG’s workstreams will include:


• Looking at accreditation


of undergraduate and postgraduate programmes of education; • Supporting the development of training for assistant practitioners in nuclear medicine, and • Working with other professional bodies to harmonise or align training schemes and qualifications amongst the various craft groups involved. If you’re interested in the


group’s work and would like further information, visit the Nuclear Medicine section of the website (bit. ly/1l20FxM).


Attention all plain film advanced practitioners in the Midlands/North West Region!


Our next FREE event is being held on Wednesday 5 March at 6pm. Hosted by The University Hospitals of Coventry &


Warwickshire. Itinery to be announced. Kindly sponsored by RIG HealthCare.


For more details please contact julie.barr@uhcw.nhs.uk


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40